Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia

被引:0
作者
Huan Chen
Kai-yan Liu
Lan-ping Xu
Dai-hong Liu
Yu-hong Chen
Xiang-yu Zhao
Wei Han
Xiao-hui Zhang
Yu Wang
Yuan-yuan Zhang
Ya-zhen Qin
Yan-rong Liu
Xiao-jun Huang
机构
[1] Peking University People’s Hospital,
[2] Peking University Institute of Hematology,undefined
[3] Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,undefined
[4] Peking University People’s Hospital,undefined
[5] Peking University Institute of Hematology,undefined
来源
Journal of Hematology & Oncology | / 5卷
关键词
Philadelphia chromosome; Acute lymphoblastic leukemia; Allogeneic hematopoietic cell transplantation; Minimal residual disease; Imatinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 162 条
[11]  
Snyder DS(2005)Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia Blood 106 458-2793
[12]  
Slovak ML(2003)Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation Biol Blood Marrow Transplant 9 206-297
[13]  
Xu LP(2007)Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia Blood 109 2791-397
[14]  
Huang XJ(2006)Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplant 38 291-323
[15]  
Liu KY(2008)Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia–feasibility and safety study J Clin Immunol 28 390-2486
[16]  
Chen Huan(2008)Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response Int J Lab Hematol 30 317-2357
[17]  
Liu DH(2003)Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQPCR)—a Europe against cancer program Leukemia 17 2474-252
[18]  
Zhang YC(2003)Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—a Europe Against Cancer program Leukemia 17 2318-113
[19]  
Wei G(2011)Administration of imatinib in first 90 days after allogeneic hematopoistic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia Chin Med J 124 246-5181
[20]  
Rafiyath S(2009)Allo-hematopoietic cell transplantation for Ph chromosome–positive ALL: impact of imatinib on relapse and survival Bone Marrow Transplant 43 107-884